Niki BioSolutions, Inc. (NIKI) Net Margin (2017 - 2025)
Niki BioSolutions' (NIKI) quarterly Net Margin came in at 728.61% in Q4 2025, down 68320.0% YoY from N/an in Q4 2024, and down 182.66% on a QoQ basis from 257.77% in Q3 2025.
Niki BioSolutions, Inc. (NIKI) Net Margin (2017 - 2025) Analysis & Trends
Niki BioSolutions (NIKI) has 3 years of Net Margin data on file, last reported at 728.61% in Q4 2025.
- Quarterly Net Margin fell 68320.0% year-over-year to 728.61% in Q4 2025, while the trailing twelve-month figure through Nov 2025 was 112.41% (changed N/A YoY) and the FY2025 annual result came in at 117.65%, up 7109.0% from the prior year.
- Net Margin eased to 728.61% in Q4 2025, from 257.77% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 45.41% in Q4 2024 to a low of 728.61% in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | -728.61% |
| Aug 31, 2025 | -257.77% |
| Nov 30, 2024 | -45.41% |
| Aug 31, 2024 | -84.41% |
| Dec 31, 2017 | 566.78% |